Zauderer MG, Tsao AS, Dao T, et al. A randomized phase II trial of adjuvant galinpepimut - S, WT-1 analogue peptide vaccine, after multimodality therapy for patients with malignant SELLAS Life Sciences Group Galinpepimut -S Protocol : SLS17 -201/ MK3475 -770 Protocol v1.1 (Amendment 1.0) 12 April 2019 Page 257 pleural mesothelioma. Clin Cancer Res.